Showing 13 of 173 recruiting trials for “squamous-cell-carcinoma-of-the-hypopharynx”
Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma
A Randomized Controlled Trial Evaluating of Prophylactic Irradiation in CRT for cT1bN0M0 ESCC
RecruitingNCT04547673 ↗
To Develop and Validate a Nasoendoscopic Intelligent Diagnostic System for Nasopharyngeal Carcinoma
👨⚕️ Weiping Wen, Ph.D, Otolaryngology Department, First Affiliated Hospital of Sun Yat-sen University📍 3 sites📅 Started Jun 2020View details ↗
RecruitingNCT04085900 ↗
Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City
👨⚕️ Mingfang Ji, MD, Zhongshan People's Hospital, Guangdong, China📍 2 sites📅 Started Apr 2020View details ↗
RecruitingNCT04544969 ↗
Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC
PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients
Phase III Study of Concurrent Radiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESO-Shanghai 15)
Study on Adjuvant Chemotherapy After Total Two-field Lymph Node Dissection of Thoracic Esophageal Squamous Cell Carcinoma
Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903)
The Protection of Thyroid Function in IMRT for Nasopharyngeal Carcinoma
RecruitingNCT04522687 ↗
Influence of Radiotherapy and Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets Among Thoracic Cancer
RecruitingNCT06476067 ↗
Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma
RecruitingNCT06490003 ↗
Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma
← PreviousPage 9 of 9
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →